Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2026
An Explainable Machine Learning Model for Predicting Short-Term Haemodynamic Changes Post-TIPS With Prognostic ImplicationsLi Ma, Jingqin Ma, Yaozu Liu, et al.
Disease Markers|February 3, 2022
Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular CarcinomaYongjie Zhou, Liangwen Wang, Wen Zhang, et al.
Journal of Hepatocellular Carcinoma|October 31, 2023
Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular CarcinomaYanjie Yang, Nan Du, Jingqin Ma, et al.
Hepatology International|February 12, 2026
Coaxial stent TIPS with 5 to 8 mm controlled expansion improving overall prognosis in cirrhotic patients: a prospective cohort study with target trial emulationLi Ma, Jingqin Ma, Jiaze Yu, et al.
Bone Research|February 5, 2026
Sulfated chitosan mitigates acute lung injury induced bone loss via immunoregulationYongxian Liu, Luli Ji, Fuwei Zhu, et al.
Hepatology International|September 18, 2025
Comparison of the impact of shunting the left versus right portal vein branch during TIPS on the postoperative overt hepatic encephalopathy: a randomized trialYongjie Zhou, Jingqin Ma, Yaozu Liu, et al.
Discover Oncology|November 22, 2023
Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experimentsWen Zhang, Nan Du, Liangwen Wang, et al.
Disease Markers|September 23, 2022
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular CarcinomaYongjie Zhou, Xin Zhou, Qingxin Liu, et al.
BMC Gastroenterology|April 11, 2025
Correlation and consistency analysis between various indirect portal pressure gradients and actual portal pressure gradientRufeng Chen, Yaozu Liu, Li Ma, et al.
Frontiers in Immunology|January 27, 2023
Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intoleranceQin Shi, Xin Zhou, Zihan Zhang, et al.
Pageof 4